Global Microbiome Therapies Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 106
Inquire Before Buying

Global Microbiome Therapies Scope and Market Size

Microbiome Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Microbiome Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Bacteria

- Fungi

- Virus

- Others

Segment by Application

- Testing Centres

- Research Labs

- Horticulture

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- uBiome

- Evolve BioSystems

- Indigo Agriculture

- Pivot Bio

- Concentric Ag

- Epibiome

- CosmosID

- Human Longevity

- Ajinomoto Cambrooke

- AnimalBiome

Global Microbiome Therapies Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbiome Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Bacteria
1.2.3 Fungi
1.2.4 Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microbiome Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Testing Centres
1.3.3 Research Labs
1.3.4 Horticulture
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microbiome Therapies Market Perspective (2016-2027)
2.2 Microbiome Therapies Growth Trends by Regions
2.2.1 Microbiome Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Microbiome Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Microbiome Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Microbiome Therapies Industry Dynamic
2.3.1 Microbiome Therapies Market Trends
2.3.2 Microbiome Therapies Market Drivers
2.3.3 Microbiome Therapies Market Challenges
2.3.4 Microbiome Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbiome Therapies Players by Revenue
3.1.1 Global Top Microbiome Therapies Players by Revenue (2016-2021)
3.1.2 Global Microbiome Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Microbiome Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microbiome Therapies Revenue
3.4 Global Microbiome Therapies Market Concentration Ratio
3.4.1 Global Microbiome Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbiome Therapies Revenue in 2020
3.5 Microbiome Therapies Key Players Head office and Area Served
3.6 Key Players Microbiome Therapies Product Solution and Service
3.7 Date of Enter into Microbiome Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Therapies Breakdown Data by Type
4.1 Global Microbiome Therapies Historic Market Size by Type (2016-2021)
4.2 Global Microbiome Therapies Forecasted Market Size by Type (2022-2027)
5 Microbiome Therapies Breakdown Data by Application
5.1 Global Microbiome Therapies Historic Market Size by Application (2016-2021)
5.2 Global Microbiome Therapies Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Microbiome Therapies Market Size (2016-2027)
6.2 North America Microbiome Therapies Market Size by Type
6.2.1 North America Microbiome Therapies Market Size by Type (2016-2021)
6.2.2 North America Microbiome Therapies Market Size by Type (2022-2027)
6.2.3 North America Microbiome Therapies Market Size by Type (2016-2027)
6.3 North America Microbiome Therapies Market Size by Application
6.3.1 North America Microbiome Therapies Market Size by Application (2016-2021)
6.3.2 North America Microbiome Therapies Market Size by Application (2022-2027)
6.3.3 North America Microbiome Therapies Market Size by Application (2016-2027)
6.4 North America Microbiome Therapies Market Size by Country
6.4.1 North America Microbiome Therapies Market Size by Country (2016-2021)
6.4.2 North America Microbiome Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Microbiome Therapies Market Size (2016-2027)
7.2 Europe Microbiome Therapies Market Size by Type
7.2.1 Europe Microbiome Therapies Market Size by Type (2016-2021)
7.2.2 Europe Microbiome Therapies Market Size by Type (2022-2027)
7.2.3 Europe Microbiome Therapies Market Size by Type (2016-2027)
7.3 Europe Microbiome Therapies Market Size by Application
7.3.1 Europe Microbiome Therapies Market Size by Application (2016-2021)
7.3.2 Europe Microbiome Therapies Market Size by Application (2022-2027)
7.3.3 Europe Microbiome Therapies Market Size by Application (2016-2027)
7.4 Europe Microbiome Therapies Market Size by Country
7.4.1 Europe Microbiome Therapies Market Size by Country (2016-2021)
7.4.2 Europe Microbiome Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Microbiome Therapies Market Size (2016-2027)
8.2 Asia-Pacific Microbiome Therapies Market Size by Type
8.2.1 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Microbiome Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Microbiome Therapies Market Size by Application
8.3.1 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Microbiome Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Microbiome Therapies Market Size by Region
8.4.1 Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Microbiome Therapies Market Size (2016-2027)
9.2 Latin America Microbiome Therapies Market Size by Type
9.2.1 Latin America Microbiome Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Microbiome Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Microbiome Therapies Market Size by Type (2016-2027)
9.3 Latin America Microbiome Therapies Market Size by Application
9.3.1 Latin America Microbiome Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Microbiome Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Microbiome Therapies Market Size by Application (2016-2027)
9.4 Latin America Microbiome Therapies Market Size by Country
9.4.1 Latin America Microbiome Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Microbiome Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbiome Therapies Market Size (2016-2027)
10.2 Middle East & Africa Microbiome Therapies Market Size by Type
10.2.1 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Microbiome Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Microbiome Therapies Market Size by Application
10.3.1 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Microbiome Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Microbiome Therapies Market Size by Country
10.4.1 Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 uBiome
11.1.1 uBiome Company Details
11.1.2 uBiome Business Overview
11.1.3 uBiome Microbiome Therapies Introduction
11.1.4 uBiome Revenue in Microbiome Therapies Business (2016-2021)
11.1.5 uBiome Recent Development
11.2 Evolve BioSystems
11.2.1 Evolve BioSystems Company Details
11.2.2 Evolve BioSystems Business Overview
11.2.3 Evolve BioSystems Microbiome Therapies Introduction
11.2.4 Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021)
11.2.5 Evolve BioSystems Recent Development
11.3 Indigo Agriculture
11.3.1 Indigo Agriculture Company Details
11.3.2 Indigo Agriculture Business Overview
11.3.3 Indigo Agriculture Microbiome Therapies Introduction
11.3.4 Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021)
11.3.5 Indigo Agriculture Recent Development
11.4 Pivot Bio
11.4.1 Pivot Bio Company Details
11.4.2 Pivot Bio Business Overview
11.4.3 Pivot Bio Microbiome Therapies Introduction
11.4.4 Pivot Bio Revenue in Microbiome Therapies Business (2016-2021)
11.4.5 Pivot Bio Recent Development
11.5 Concentric Ag
11.5.1 Concentric Ag Company Details
11.5.2 Concentric Ag Business Overview
11.5.3 Concentric Ag Microbiome Therapies Introduction
11.5.4 Concentric Ag Revenue in Microbiome Therapies Business (2016-2021)
11.5.5 Concentric Ag Recent Development
11.6 Epibiome
11.6.1 Epibiome Company Details
11.6.2 Epibiome Business Overview
11.6.3 Epibiome Microbiome Therapies Introduction
11.6.4 Epibiome Revenue in Microbiome Therapies Business (2016-2021)
11.6.5 Epibiome Recent Development
11.7 CosmosID
11.7.1 CosmosID Company Details
11.7.2 CosmosID Business Overview
11.7.3 CosmosID Microbiome Therapies Introduction
11.7.4 CosmosID Revenue in Microbiome Therapies Business (2016-2021)
11.7.5 CosmosID Recent Development
11.8 Human Longevity
11.8.1 Human Longevity Company Details
11.8.2 Human Longevity Business Overview
11.8.3 Human Longevity Microbiome Therapies Introduction
11.8.4 Human Longevity Revenue in Microbiome Therapies Business (2016-2021)
11.8.5 Human Longevity Recent Development
11.9 Ajinomoto Cambrooke
11.9.1 Ajinomoto Cambrooke Company Details
11.9.2 Ajinomoto Cambrooke Business Overview
11.9.3 Ajinomoto Cambrooke Microbiome Therapies Introduction
11.9.4 Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021)
11.9.5 Ajinomoto Cambrooke Recent Development
11.10 AnimalBiome
11.10.1 AnimalBiome Company Details
11.10.2 AnimalBiome Business Overview
11.10.3 AnimalBiome Microbiome Therapies Introduction
11.10.4 AnimalBiome Revenue in Microbiome Therapies Business (2016-2021)
11.10.5 AnimalBiome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Microbiome Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Bacteria
Table 3. Key Players of Fungi
Table 4. Key Players of Virus
Table 5. Key Players of Others
Table 6. Global Microbiome Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Microbiome Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Microbiome Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Microbiome Therapies Market Share by Regions (2016-2021)
Table 10. Global Microbiome Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Microbiome Therapies Market Share by Regions (2022-2027)
Table 12. Microbiome Therapies Market Trends
Table 13. Microbiome Therapies Market Drivers
Table 14. Microbiome Therapies Market Challenges
Table 15. Microbiome Therapies Market Restraints
Table 16. Global Microbiome Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Microbiome Therapies Market Share by Players (2016-2021)
Table 18. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020)
Table 19. Ranking of Global Top Microbiome Therapies Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Microbiome Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Microbiome Therapies Product Solution and Service
Table 23. Date of Enter into Microbiome Therapies Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
Table 27. Global Microbiome Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Microbiome Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Microbiome Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Microbiome Therapies Revenue Market Share by Application (2016-2021)
Table 31. Global Microbiome Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Microbiome Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Microbiome Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Microbiome Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Microbiome Therapies Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Microbiome Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Microbiome Therapies Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Microbiome Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Microbiome Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Microbiome Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 63. uBiome Company Details
Table 64. uBiome Business Overview
Table 65. uBiome Microbiome Therapies Product
Table 66. uBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 67. uBiome Recent Development
Table 68. Evolve BioSystems Company Details
Table 69. Evolve BioSystems Business Overview
Table 70. Evolve BioSystems Microbiome Therapies Product
Table 71. Evolve BioSystems Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 72. Evolve BioSystems Recent Development
Table 73. Indigo Agriculture Company Details
Table 74. Indigo Agriculture Business Overview
Table 75. Indigo Agriculture Microbiome Therapies Product
Table 76. Indigo Agriculture Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 77. Indigo Agriculture Recent Development
Table 78. Pivot Bio Company Details
Table 79. Pivot Bio Business Overview
Table 80. Pivot Bio Microbiome Therapies Product
Table 81. Pivot Bio Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 82. Pivot Bio Recent Development
Table 83. Concentric Ag Company Details
Table 84. Concentric Ag Business Overview
Table 85. Concentric Ag Microbiome Therapies Product
Table 86. Concentric Ag Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 87. Concentric Ag Recent Development
Table 88. Epibiome Company Details
Table 89. Epibiome Business Overview
Table 90. Epibiome Microbiome Therapies Product
Table 91. Epibiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 92. Epibiome Recent Development
Table 93. CosmosID Company Details
Table 94. CosmosID Business Overview
Table 95. CosmosID Microbiome Therapies Product
Table 96. CosmosID Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 97. CosmosID Recent Development
Table 98. Human Longevity Company Details
Table 99. Human Longevity Business Overview
Table 100. Human Longevity Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 101. Human Longevity Recent Development
Table 102. Ajinomoto Cambrooke Company Details
Table 103. Ajinomoto Cambrooke Business Overview
Table 104. Ajinomoto Cambrooke Microbiome Therapies Product
Table 105. Ajinomoto Cambrooke Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 106. Ajinomoto Cambrooke Recent Development
Table 107. AnimalBiome Company Details
Table 108. AnimalBiome Business Overview
Table 109. AnimalBiome Microbiome Therapies Product
Table 110. AnimalBiome Revenue in Microbiome Therapies Business (2016-2021) & (US$ Million)
Table 111. AnimalBiome Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Microbiome Therapies Market Share by Type: 2020 VS 2027
Figure 2. Bacteria Features
Figure 3. Fungi Features
Figure 4. Virus Features
Figure 5. Others Features
Figure 6. Global Microbiome Therapies Market Share by Application: 2020 VS 2027
Figure 7. Testing Centres Case Studies
Figure 8. Research Labs Case Studies
Figure 9. Horticulture Case Studies
Figure 10. Others Case Studies
Figure 11. Microbiome Therapies Report Years Considered
Figure 12. Global Microbiome Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Microbiome Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Microbiome Therapies Market Share by Regions: 2020 VS 2027
Figure 15. Global Microbiome Therapies Market Share by Regions (2022-2027)
Figure 16. Global Microbiome Therapies Market Share by Players in 2020
Figure 17. Global Top Microbiome Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microbiome Therapies as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Microbiome Therapies Revenue in 2020
Figure 19. Global Microbiome Therapies Revenue Market Share by Type (2016-2021)
Figure 20. Global Microbiome Therapies Revenue Market Share by Type (2022-2027)
Figure 21. North America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Microbiome Therapies Market Share by Type (2016-2027)
Figure 23. North America Microbiome Therapies Market Share by Application (2016-2027)
Figure 24. North America Microbiome Therapies Market Share by Country (2016-2027)
Figure 25. United States Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Microbiome Therapies Market Share by Type (2016-2027)
Figure 29. Europe Microbiome Therapies Market Share by Application (2016-2027)
Figure 30. Europe Microbiome Therapies Market Share by Country (2016-2027)
Figure 31. Germany Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Microbiome Therapies Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Microbiome Therapies Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Microbiome Therapies Market Share by Region (2016-2027)
Figure 41. China Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Microbiome Therapies Market Share by Type (2016-2027)
Figure 49. Latin America Microbiome Therapies Market Share by Application (2016-2027)
Figure 50. Latin America Microbiome Therapies Market Share by Country (2016-2027)
Figure 51. Mexico Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Microbiome Therapies Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Microbiome Therapies Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Microbiome Therapies Market Share by Country (2016-2027)
Figure 57. Turkey Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Microbiome Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. uBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 61. Evolve BioSystems Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 62. Indigo Agriculture Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 63. Pivot Bio Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 64. Concentric Ag Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 65. Epibiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 66. CosmosID Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 67. Human Longevity Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 68. Ajinomoto Cambrooke Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 69. AnimalBiome Revenue Growth Rate in Microbiome Therapies Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs